Bioactive glass and silicate-based ceramic coatings on metallic implants: open challenge or outdated topic?

G Brunello, H Elsayed, L Biasetto - Materials, 2019 - mdpi.com
The overall success and long-term life of the medical implants are decisively based on the
convenient osseointegration at the hosting tissue-implant interface. Therefore, various …

Optimized bioactive glass: the quest for the bony graft

H Granel, C Bossard, L Nucke… - Advanced …, 2019 - Wiley Online Library
Technological advances have provided surgeons with a wide range of biomaterials. Yet
improvements are still to be made, especially for large bone defect treatment. Biomaterial …

[HTML][HTML] S53P4 bioactive glass scaffolds induce BMP expression and integrative bone formation in a critical-sized diaphysis defect treated with a single-staged …

E Eriksson, R Björkenheim, G Strömberg, M Ainola… - Acta Biomaterialia, 2021 - Elsevier
Critical-sized diaphysis defects are complicated by inherent sub-optimal healing conditions.
The two-staged induced membrane technique has been used to treat these challenging …

Antimicrobial activity of bioactive glass S53P4 against representative microorganisms causing osteomyelitis–real-time assessment by isothermal microcalorimetry

MG Moreno, ME Butini, EM Maiolo, L Sessa… - Colloids and Surfaces B …, 2020 - Elsevier
Bioactive glass (BAG) is a synthetic bone substitute with intrinsic antimicrobial properties,
used for bone defect filling. We evaluated the antimicrobial activity of two formulations of …

Sintered nanoporous biosilica diatom frustules as high efficiency cell-growth and bone-mineralisation platforms

A Amoda, L Borkiewicz, A Rivero-Müller… - Materials Today …, 2020 - Elsevier
In this paper, we disclose a novel biomaterial with a considerable capacity for cell growth
and bone mineralisation. The biomaterial is manufactured by sintering diatom …

Matched-pair analysis: Large-sized defects in surgery of lower limb nonunions

S Findeisen, M Schwilk, P Haubruck, T Ferbert… - Journal of Clinical …, 2023 - mdpi.com
Background: The treatment of large-sized bone defects remains a major challenge in trauma
and orthopaedic surgery. Although there are many treatment options, there is still no clear …

[PDF][PDF] Sintered S53P4 bioactive glass scaffolds have anti-inflammatory properties and stimulate osteogenesis in vitro

R Björkenheim, E Jämsen, E Eriksson, P Uppstu… - Eur. Cells …, 2021 - helda.helsinki.fi
Bioactive glasses (BAG) are used as bone-graft substitutes in orthopaedic surgery. A
specific BAG scaffold was developed by sintering BAG-S53P4 granules. It is hypothesised …

Treatment of Bone Defects and Nonunion via Novel Delivery Mechanisms, Growth Factors, and Stem Cells: A Review

QT Ehlen, JP Costello, NA Mirsky… - ACS Biomaterials …, 2024 - ACS Publications
Bone nonunion following a fracture represents a significant global healthcare challenge,
with an overall incidence ranging between 2 and 10% of all fractures. The management of …

[HTML][HTML] Treatment of infected tibial non-unions using a BMAC and S53P4 BAG combination for reconstruction of segmental bone defects: A clinical case series

TAG Van Vugt, JAP Geurts, TJ Blokhuis - Injury, 2021 - Elsevier
Introduction Treatment of infected non-unions of the tibia is a challenging problem. The
cornerstones of optimal infected non-union treatment consist of extensive debridement …

[HTML][HTML] The apatite-forming ability of bioactive glasses–A comparative study in human serum and Kokubo's simulated body fluid

A Szewczyk, A Skwira-Rucińska, M Osińska… - Ceramics …, 2024 - Elsevier
Currently, the apatite-forming ability evaluation of a biomaterial employs Kokubo's simulated
body fluid (SBF) as a testing medium. As the conventional SBF simulates only the ionic …